Singapore: Antisense Therapeutics, an Australian publicly listed biopharmaceutical drug discovery and development company, will conduct a chronic toxicology study to support a potential future phase IIb study of ATL1102 in multiple sclerosis... Read more
"Don't just think you are the one. Know that you are the one." This famous line from the movie Matrix motivates me a lot.... Read more
Singapore: Crystal Pharmatech, a technology-driven solid-state research contract research organization (CRO) based China,... Read more
Pharmaceutical and biotechnology companies reap the most benefit from their strategic collaborations, by working with suppliers whose practices... Read more
Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900s. This history... Read more
Over the past few years, a significant shift has occurred in the depth and type of relationships that the pharmaceutical... Read more
Growth of the biotech industry in Singapore over the last 10 years has, in a number of measures, outpaced the... Read more
The conventional view of contract research organizations (CROs) bears little relationship with the way in which they were perceived ten... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
